Eisai Co., Ltd. announced that the European Medicines Agency (EMA) has accepted for evaluation a marketing authorization application (MAA) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE